Alps Advisors Inc Kronos Bio, Inc. Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.35 - $5.55 $8,766 - $14,524	-2,617 Reduced 7.78%	31,034 $104,000
Q2 2022 Aug 11, 2022	SELL	$3.12 - $7.52 $76,518 - $184,428	-24,525 Reduced 42.16%	33,651 $122,000
Q1 2022 May 16, 2022	SELL	$6.26 - $14.42 $44,045 - $101,459	-7,036 Reduced 10.79%	58,176 $421,000
Q4 2021 Feb 09, 2022	BUY	$11.35 - $21.18 $740,156 - $1.38 Million	65,212 New	65,212 $886,000

20.7M

31.4K

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.